Evidence map›Paper›PMID 35285800›Full record

ArticleeLife2022

Activation of the CaMKII-Sarm1-ASK1-p38 MAP kinase pathway protects against axon degeneration caused by loss of mitochondria.

Chen Ding, Youjun Wu, Hadas Dabas, Marc Hammarlund

Open access · goldAbstract read
In one paragraph

Article in eLife, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
3.5field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 45 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Neuromodulation of swarming behavior inProceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  7. eNeuro · 2026
    Article
  8. Article
  9. Neuromodulation of Swarming Behavior inbioRxiv : the preprint server for biology · 2025
    Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Nervous system-wide analysis of allScience advances · 2025
    Article
  15. Emerging interactions between mitochondria and NADTrends in endocrinology and metabolism: TEM · 2025
    Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Chen DingDepartment of Neuroscience, Yale University School of Medicine, New Haven, United States.ORCID 0000-0002-1054-9668
Youjun WuDepartment of Genetics, Yale University School of Medicine, New Haven, United States.
Hadas DabasDepartment of Genetics, Yale University School of Medicine, New Haven, United States.ORCID 0000-0002-6654-0873
Marc HammarlundDepartment of Neuroscience, Yale University School of Medicine, New Haven, United States.ORCID 0000-0002-3068-068X
Yale University · US

Funding

New Mechanisms in Axon RegenerationR01NS094219 · NINDS · YALE UNIVERSITY · PI HAMMARLUND, MARC · 2015 to 2025
$4.0M
Evaluation of Novel Axon Regeneration Targets for Spinal Cord injury TherapyR01NS098817 · NINDS · YALE UNIVERSITY · PI HAMMARLUND, MARC, STRITTMATTER, STEPHEN M · 2016 to 2020
$1.4M
NINDS NIH HHS R01 NS094219NINDS NIH HHS R01 NS098817
6 · The paper itself

Abstract

Mitochondrial defects are tightly linked to axon degeneration, yet the underlying cellular mechanisms remain poorly understood. In

Indexed as

Armadillo Domain ProteinsCaenorhabditis elegans ProteinsAnimalsAxonsCaenorhabditis elegansCalcium-Calmodulin-Dependent Protein Kinase Type 2Cytoskeletal ProteinsMembrane ProteinsMitochondriap38 Mitogen-Activated Protein KinasesArmadillo Domain ProteinsCaenorhabditis elegans ProteinsCalcium-Calmodulin-Dependent Protein Kinase Type 2Cytoskeletal Proteinslin-10 protein, C elegansMembrane Proteinsp38 Mitogen-Activated Protein Kinasesaxon degenerationcalsynteninCaMKIIC. eleganscell biologyMAPK signalingmitochondrianeuroscienceSarm1

Identifiers

PMID35285800
PMCPMC8920508
OpenAlexW4220878757

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.